Clinical studies involving probiotics: when FDA's investigational new drug rubric applies-and when it may not.

Authors:
Degnan FH.

Journal:
Gut Microbes

Publication Year: 2012

DOI:
10.4161/gmic.22158

PMCID:
PMC3495785

PMID:
23060015

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Gut Microbes

Abbreviation: Gut Microbes

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulation.
Shi B; Li H; He X. (2024) - Transparency Score: 2/6
Antibiotic-induced gut dysbiosis elicits gut-brain axis relevant multi-omic signatures and behavior…
Hayer SS; Conrin M; French JA and 14 more (2024) - Transparency Score: 4/6
Anti-S-layer monoclonal antibodies impact <i>Clostridioides difficile</i> physiology.
Hunault L; Auria E; England P and 13 more (2024) - Transparency Score: 3/6
A synthetic microbial consortium protects against obesity by regulating vitamin B6 metabolism.
Chen X; Gao M; Wang L and 4 more (2024) - Transparency Score: 3/6
A tailored series of engineered yeasts for the cell-dependent treatment of inflammatory bowel disea…
Wu J; Huang H; Wang L and 9 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
0/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025